Redmile Group, LLC Beam Therapeutics Inc. Transaction History

Redmile Group, LLC

  • $1.53 Billion
  • Q3 2024

A detailed history of Redmile Group, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 1,611,013 shares of BEAM stock, worth $46.7 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares
1,611,013
Previous 1,703,061 5.4%
Holding current value
$46.7 Million
Previous $39.9 Million 1.09%
% of portfolio
2.58%
Previous 2.6%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$22.57 - $33.14 $2.08 Million - $3.05 Million
-92,048 Reduced 5.4%
1,611,013 $39.5 Million
Q2 2024

Aug 14, 2024
SELL
$21.22 - $32.66 $3.75 Million - $5.77 Million
-176,556 Reduced 9.39%
1,703,061 $39.9 Million
Q1 2024

May 15, 2024
BUY
$23.46 - $45.07 $10.6 Million - $20.3 Million
449,834 Added 31.46%
1,879,617 $62.1 Million
Q4 2023

Feb 14, 2024
SELL
$17.69 - $30.76 $980,309 - $1.7 Million
-55,416 Reduced 3.73%
1,429,783 $38.9 Million
Q2 2023

Aug 14, 2023
SELL
$29.32 - $35.99 $3.72 Million - $4.57 Million
-126,895 Reduced 7.87%
1,485,199 $47.4 Million
Q1 2023

May 15, 2023
SELL
$30.15 - $48.79 $4.78 Million - $7.73 Million
-158,493 Reduced 8.95%
1,612,094 $49.4 Million
Q4 2022

Feb 14, 2023
SELL
$36.73 - $51.6 $88,151 - $123,840
-2,400 Reduced 0.14%
1,770,587 $69.2 Million
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $3.06 Million - $5.41 Million
-76,900 Reduced 4.16%
1,772,987 $84.5 Million
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $413,172 - $862,875
13,837 Added 0.75%
1,849,887 $71.6 Million
Q1 2022

May 16, 2022
SELL
$53.73 - $82.16 $2.68 Million - $4.09 Million
-49,800 Reduced 2.64%
1,836,050 $105 Million
Q4 2021

Feb 14, 2022
SELL
$68.02 - $99.06 $6.06 Million - $8.83 Million
-89,156 Reduced 4.51%
1,885,850 $150 Million
Q3 2021

Nov 15, 2021
SELL
$84.37 - $133.6 $6.54 Million - $10.4 Million
-77,500 Reduced 3.78%
1,975,006 $172 Million
Q2 2021

Aug 16, 2021
SELL
$64.12 - $128.71 $30.8 Million - $61.8 Million
-480,017 Reduced 18.95%
2,052,506 $264 Million
Q1 2021

May 17, 2021
SELL
$71.28 - $120.75 $88.8 Million - $150 Million
-1,245,739 Reduced 32.97%
2,532,523 $203 Million
Q4 2020

Feb 16, 2021
BUY
$22.24 - $95.63 $10 Million - $43.1 Million
451,000 Added 13.55%
3,778,262 $308 Million
Q3 2020

Nov 16, 2020
SELL
$19.0 - $30.57 $564,224 - $907,806
-29,696 Reduced 0.88%
3,327,262 $81.9 Million
Q2 2020

Aug 14, 2020
SELL
$15.26 - $28.66 $35,098 - $65,918
-2,300 Reduced 0.07%
3,356,958 $94 Million
Q1 2020

May 15, 2020
BUY
$13.31 - $29.2 $44.7 Million - $98.1 Million
3,359,258 New
3,359,258 $60.5 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email